With a fast-growing pipeline of siRNA and mRNA drugs, San Diego startup Arcturus Therapeutics is poised join the ranks of more established RNA-based drug companies like Alnylam and Moderna Therapeutics. It’s welcome timing, as the market’s cast a keen eye on RNA therapies. Once a biotech underdog, scientists are finding that the gene modifying potential of these RNA therapeutics can alter the course of disease … Continue reading Arcturus emerging as a strong player in RNA therapeutics space